Astrana Health Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +25.3% | -69.0% | +288.0% | +46.5% | -132.2% | – | +446.7% | -89.0% | -129.0% | – | +48.1% | – | |
| – | +13.9% | +4.0% | +46.0% | -2.4% | +11.9% | -15.7% | +0.8% | +125.9% | +5.2% | -5.6% | +100.5% | – | |
| – | +52.1% | -33.7% | +28.6% | -16.6% | +147.2% | -48.7% | +49.9% | -34.2% | +47.8% | -13.1% | +119.1% | – | |
| – | – | -303.4% | – | – | -181.8% | – | – | -126.2% | – | – | -28.6% | – | |
| – | +71.9% | -94.8% | +668.6% | -19.1% | +10.3% | +21.3% | -53.7% | +79.7% | +20.1% | +30.5% | +97.0% | – | |
| – | -67.2% | +520.6% | +12.7% | -89.9% | +311.1% | -92.8% | -56.2% | +50,850.5% | -99.8% | +169.1% | +219.0% | – | |
| – | +4,100.0% | -99.8% | +1,795.8% | -87.9% | +781.7% | +183.8% | -85.7% | -87.7% | +1,520.8% | -93.3% | +91.3% | – | |
| – | +235.3% | -100.0% | – | -80.0% | -69.3% | +498.2% | – | -138.7% | +2,931.2% | -81.2% | +50.2% | – | |
| – | – | – | – | – | +77.0% | +321.5% | -81.8% | – | -101.8% | +0.0% | +668.5% | – | |
| – | – | +785.7% | -55.5% | -106.8% | +378.6% | +189.3% | -80.4% | – | -104.1% | -39.4% | +652.1% | – | |
| – | – | +106.3% | -123.1% | – | -362.5% | – | – | +50.9% | -124.7% | – | -157.9% | – | |
| – | +8.3% | -54.2% | +262.9% | +55.7% | -142.5% | – | +560.0% | -91.7% | -180.4% | – | +45.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.